The Science Behind Telomere Lengthening Through Peptide Therapy AEDG Pineal Peptide Research Foundations Epithalons development traces back to research conducted by Professor Vladimir Khavinson in Russia, beginning in the 1980s
It might take months or years for someone to lose a sufficient amount of weight for there to be a resolution or improvement of their sleep apnea, he says, noting that these patients will need to be treated in another way during this time
It possesses various pharmacological properties, including immunomodulatory and anti-aging effects (Zhu et al., 2015
This is due to the increased melanin production in the skin and may be more noticeable in people with lighter skin
Escher M, Desmeules J, Giostra E, Mentha G
Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume